Who invested in CG Oncology?
4 investors are on record as having backed CG Oncology — Developing bladder-sparing immunotherapies for bladder cancer, in Biotech, United States. Each row below says whether the round came from the investor's own portfolio page or from the press.
cgoncology.comCG Oncology investors
Foresite Capital Management, LLCMulti-stage healthcare and life sciences investor using data science to back companies at…their site
Longitude Capital Management Co., LLCVenture growth investor backing de-risked clinical and commercial healthcare companies to…their site
2 more investors on record for CG Oncology.
The first two are open to everyone. A free account opens the rest — the fund, the round, the amount and where each number came from. No card, no demo call.
No round dates are on record for CG Oncology. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed CG Oncology are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.